194 related articles for article (PubMed ID: 34203690)
1. Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.
Flynn NR; Ward MD; Schleiff MA; Laurin CMC; Farmer R; Conway SJ; Boysen G; Swamidass SJ; Miller GP
Metabolites; 2021 Jun; 11(6):. PubMed ID: 34203690
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Bioactivation and Subsequent Reactivity of Drugs.
Hughes TB; Flynn N; Dang NL; Swamidass SJ
Chem Res Toxicol; 2021 Feb; 34(2):584-600. PubMed ID: 33496184
[TBL] [Abstract][Full Text] [Related]
3. Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics.
Schleiff MA; Flynn NR; Payakachat S; Schleiff BM; Pinson AO; Province DW; Swamidass SJ; Boysen G; Miller GP
Drug Metab Dispos; 2021 Feb; 49(2):133-141. PubMed ID: 33239334
[TBL] [Abstract][Full Text] [Related]
4. The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkylcatechol-induced toxicity in human melanoma cells.
Bolton JL; Pisha E; Shen L; Krol ES; Iverson SL; Huang Z; van Breemen RB; Pezzuto JM
Chem Biol Interact; 1997 Sep; 106(2):133-48. PubMed ID: 9366899
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.
Hughes TB; Swamidass SJ
Chem Res Toxicol; 2017 Feb; 30(2):642-656. PubMed ID: 28099803
[TBL] [Abstract][Full Text] [Related]
6. The influence of the p-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols.
Iverson SL; Hu LQ; Vukomanovic V; Bolton JL
Chem Res Toxicol; 1995 Jun; 8(4):537-44. PubMed ID: 7548733
[TBL] [Abstract][Full Text] [Related]
7. Impacts of diphenylamine NSAID halogenation on bioactivation risks.
Schleiff MA; Payakachat S; Schleiff BM; Swamidass SJ; Boysen G; Miller GP
Toxicology; 2021 Jun; 458():152832. PubMed ID: 34107285
[TBL] [Abstract][Full Text] [Related]
8. Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer.
Xue X; Zhang Y; Wang C; Zhang M; Xiang Q; Wang J; Wang A; Li C; Zhang C; Zou L; Wang R; Wu S; Lu Y; Chen H; Ding K; Li G; Xu Y
Eur J Med Chem; 2018 May; 152():542-559. PubMed ID: 29758518
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes.
Iverson SL; Shen L; Anlar N; Bolton JL
Chem Res Toxicol; 1996 Mar; 9(2):492-9. PubMed ID: 8839054
[TBL] [Abstract][Full Text] [Related]
10. Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole.
Bolton JL; Acay NM; Vukomanovic V
Chem Res Toxicol; 1994; 7(3):443-50. PubMed ID: 8075378
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
Thomas DJ; Sadler A; Subrahmanyam VV; Siegel D; Reasor MJ; Wierda D; Ross D
Mol Pharmacol; 1990 Feb; 37(2):255-62. PubMed ID: 2154673
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins.
Lai J; Liu Z; Zhao Y; Ma C; Huang H
Front Oncol; 2021; 11():716830. PubMed ID: 34540687
[TBL] [Abstract][Full Text] [Related]
13. The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers.
Long J; Li B; Rodriguez-Blanco J; Pastori C; Volmar CH; Wahlestedt C; Capobianco A; Bai F; Pei XH; Ayad NG; Robbins DJ
J Biol Chem; 2014 Dec; 289(51):35494-502. PubMed ID: 25355313
[TBL] [Abstract][Full Text] [Related]
14. Novel bioactivation mechanism of reactive metabolite formation from phenyl methyl-isoxazoles.
Bylund J; Macsari I; Besidski Y; Olofsson S; Petersson C; Arvidsson PI; Bueters T
Drug Metab Dispos; 2012 Nov; 40(11):2185-91. PubMed ID: 22908203
[TBL] [Abstract][Full Text] [Related]
15. Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and
Attwa MW; Kadi AA; Abdelhameed AS
RSC Adv; 2020 Jan; 10(9):5412-5427. PubMed ID: 35498318
[TBL] [Abstract][Full Text] [Related]
16. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA.
Fan PW; Bolton JL
Drug Metab Dispos; 2001 Jun; 29(6):891-6. PubMed ID: 11353759
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.
Bauman JN; Frederick KS; Sawant A; Walsky RL; Cox LM; Obach RS; Kalgutkar AS
Drug Metab Dispos; 2008 Jun; 36(6):1016-29. PubMed ID: 18332080
[TBL] [Abstract][Full Text] [Related]
19. Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes.
Dang NL; Hughes TB; Miller GP; Swamidass SJ
Chem Res Toxicol; 2017 Apr; 30(4):1046-1059. PubMed ID: 28256829
[TBL] [Abstract][Full Text] [Related]
20. Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.
Dang NL; Hughes TB; Miller GP; Swamidass SJ
Chem Res Toxicol; 2018 Feb; 31(2):68-80. PubMed ID: 29355304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
